Treatment of uremic patients with biofiltration: efficacy, biocompatibility and medium-term results.
The present report deals with a medium-term programme using biofiltration on a group of 10 patients, who underwent a regular reduced-time schedule (3 procedures per week, 3 hours duration each) lasting up to 12 months. A polyacrylonitrile AN 69 S membrane was used together with a substitution fluid containing Na and bicarbonate. Hematochemical and nutritional parameters were regularly checked to evaluate the efficacy of treatment. Biocompatibility of materials was evaluated by humoral and cellular immunological tests.
D000136:Acid-Base Equilibrium; D000180:Acrylic Resins; D000328:Adult; D001639:Bicarbonates / Q000008:administration & dosage; D001672:Biocompatible Materials; D001769:Blood; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D006435:Renal Dialysis; D013601:T-Lymphocytes / Q000276:immunology; D014462:Ultrafiltration / Q000379:methods*; D014511:Uremia / Q000628:therapy*
D000180:Acrylic Resins; D001639:Bicarbonates; D001672:Biocompatible Materials; D008567:Membranes, Artificial; C010504:polyacrylonitrile